Genetic Signatures (ASX:GSS) Price-to-Operating-Cash-Flow : (As of May. 29, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Genetic Signatures Price-to-Operating-Cash-Flow?

As of today (2024-05-29), Genetic Signatures's share price is A$0.73. Genetic Signatures's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.07. Hence, Genetic Signatures's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Genetic Signatures's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 9 years, Genetic Signatures's highest Price-to-Operating-Cash-Flow Ratio was 62.44. The lowest was 7.55. And the median was 27.11.

ASX:GSS's Price-to-Operating-Cash-Flow is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 17.27
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Genetic Signatures's Cash Flow from Operations per share for the six months ended in Dec. 2023 was A$-0.02. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.07.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -5.20% per year.

During the past 9 years, Genetic Signatures's highest 3-Year average Operating Cash Flow per Share Growth Rate was 14.80% per year. The lowest was -41.10% per year. And the median was 4.15% per year.

Genetic Signatures Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Genetic Signatures's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Signatures Price-to-Operating-Cash-Flow Chart

Genetic Signatures Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

38.37

17.17

Genetic Signatures Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial													-	17.17	-	-	-

Competitive Comparison of Genetic Signatures's Price-to-Operating-Cash-Flow

For the Diagnostics & Research subindustry, Genetic Signatures's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetic Signatures's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Signatures's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Genetic Signatures's Price-to-Operating-Cash-Flow falls into.

Genetic Signatures Price-to-Operating-Cash-Flow Calculation

Genetic Signatures's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.73	/	-0.066
	=

Genetic Signatures's Share Price of today is A$0.73.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genetic Signatures's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.07.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Genetic Signatures Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Genetic Signatures's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Signatures (ASX:GSS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Signatures Ltd (ASX:GSS) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Eliza Street, Newtown, Sydney, NSW, AUS, 2042

Website

https://www.geneticsignatures.com

Genetic Signatures Ltd proprietary PCR solutions and automated workflows routinely screen for multiple infectious diseases in a single test. Rapid and accurate results facilitate improved patient management and healthcare outcomes. GSS continues to expand its global reach with direct representation in Australia, Europe, and the United States, and growing distribution partnerships. The company operates under one business segment which is the research and commercialisation of identifying individual genetic signatures to diagnose diseases and disabilities.